133 related articles for article (PubMed ID: 29145135)
1. Forced and long-term degradation assays of tenoxicam, piroxicam and meloxicam in river water. Degradation products and adsorption to sediment.
Jiménez JJ; Muñoz BE; Sánchez MI; Pardo R
Chemosphere; 2018 Jan; 191():903-910. PubMed ID: 29145135
[TBL] [Abstract][Full Text] [Related]
2. Degradation of indomethacin in river water under stress and non-stress laboratory conditions: degradation products, long-term evolution and adsorption to sediment.
Jiménez JJ; Sánchez MI; Pardo R; Muñoz BE
J Environ Sci (China); 2017 Jan; 51():13-20. PubMed ID: 28115123
[TBL] [Abstract][Full Text] [Related]
3. Persistence of alprazolam in river water according to forced and non-forced degradation assays: adsorption to sediment and long-term degradation products.
Jiménez JJ; Sánchez MI; Muñoz BE; Pardo R
Drug Test Anal; 2017 Aug; 9(8):1204-1213. PubMed ID: 27992663
[TBL] [Abstract][Full Text] [Related]
4. Photochemical, thermal, biological and long-term degradation of celecoxib in river water. Degradation products and adsorption to sediment.
Jiménez JJ; Pardo R; Sánchez MI; Muñoz BE
J Hazard Mater; 2018 Jan; 342():252-259. PubMed ID: 28843794
[TBL] [Abstract][Full Text] [Related]
5. Fate of the drug chlorpromazine in river water according to laboratory assays. Identification and evolution over time of degradation products. Sorption to sediment.
Jiménez JJ; Muñoz BE; Sánchez MI; Pardo R; Vega MS
Chemosphere; 2016 Nov; 162():285-92. PubMed ID: 27513549
[TBL] [Abstract][Full Text] [Related]
6. Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam.
Banerjee R; Chakraborty H; Sarkar M
Spectrochim Acta A Mol Biomol Spectrosc; 2003 Apr; 59(6):1213-22. PubMed ID: 12659890
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination for oxicam non-steroidal anti-inflammatory drugs in human serum by liquid chromatography-tandem mass spectrometry.
Shirako J; Kawasaki M; Komine K; Kunisue Y; Terada M; Sasaki C; Irie W; Murakami C; Tonooka K; Tomobe K; Shinozuka T
Forensic Sci Int; 2013 Apr; 227(1-3):100-2. PubMed ID: 23273940
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of piroxicam, meloxicam and tenoxicam in human plasma by liquid chromatography with tandem mass spectrometry.
Ji HY; Lee HW; Kim YH; Jeong DW; Lee HS
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 826(1-2):214-9. PubMed ID: 16169293
[TBL] [Abstract][Full Text] [Related]
9. The reactions of oxicam and sulfoanilide non steroidal anti-inflammatory drugs with hypochlorous acid: determination of the rate constants with an assay based on the competition with para-aminobenzoic acid chlorination and identification of some oxidation products.
Van Antwerpen P; Dubois J; Gelbcke M; Neve J
Free Radic Res; 2004 Mar; 38(3):251-8. PubMed ID: 15129733
[TBL] [Abstract][Full Text] [Related]
10. Scavenging of photogenerated ROS by Oxicams. Possible biological and environmental implications.
Ferrari GV; Natera J; Paulina Montaña M; Muñoz V; Gutiérrez EL; Massad W; Miskoski S; García NA
J Photochem Photobiol B; 2015 Dec; 153():233-9. PubMed ID: 26453988
[TBL] [Abstract][Full Text] [Related]
11. Determination of pKa values of nonsteroidal antiinflammatory drug-oxicams by RP-HPLC and their analysis in pharmaceutical dosage forms.
Demiralay EC; Alsancak G; Ozkan SA
J Sep Sci; 2009 Sep; 32(17):2928-36. PubMed ID: 19662642
[TBL] [Abstract][Full Text] [Related]
12. Semi solid matrix formulations of meloxicam and tenoxicam: an in vitro and in vivo evaluation.
Alladi S; Shastri NR
Arch Pharm Res; 2015; 38(5):801-12. PubMed ID: 24752862
[TBL] [Abstract][Full Text] [Related]
13. Anti-Inflammatory Oxicams as Multi-donor Ligand Systems: pH- and Solvent-Dependent Coordination Modes of Meloxicam and Piroxicam to Ru and Os.
Aman F; Hanif M; Kubanik M; Ashraf A; Söhnel T; Jamieson SM; Siddiqui WA; Hartinger CG
Chemistry; 2017 Apr; 23(20):4893-4902. PubMed ID: 28198061
[TBL] [Abstract][Full Text] [Related]
14. Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network.
Xu S; Hermanson DJ; Banerjee S; Ghebreselasie K; Clayton GM; Garavito RM; Marnett LJ
J Biol Chem; 2014 Mar; 289(10):6799-6808. PubMed ID: 24425867
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Oxicam NSAIDs with lipid monolayer: anomalous dependence on drug concentration.
Kundu S; Chakraborty H; Sarkar M; Datta A
Colloids Surf B Biointerfaces; 2009 Apr; 70(1):157-61. PubMed ID: 19157803
[TBL] [Abstract][Full Text] [Related]
16. Non-steroidal anti-inflammatory drug induced membrane fusion: concentration and temperature effects.
Mondal S; Sarkar M
J Phys Chem B; 2009 Dec; 113(51):16323-31. PubMed ID: 19954169
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of NSAIDs in micelles: implication of structural switchover in drug-membrane interaction.
Chakraborty H; Banerjee R; Sarkar M
Biophys Chem; 2003 May; 104(1):315-25. PubMed ID: 12834850
[TBL] [Abstract][Full Text] [Related]
18. Effect of lipid molecule headgroup mismatch on non steroidal anti-inflammatory drugs induced membrane fusion.
Mondal Roy S; Sarkar M
Langmuir; 2011 Dec; 27(24):15054-64. PubMed ID: 21999838
[TBL] [Abstract][Full Text] [Related]
19. Piroxicam-induced photodermatitis. Cross-reactivity among oxicams. A case report.
Trujillo MJ; de Barrio M; Rodríguez A; Moreno-Zazo M; Sánchez I; Pelta R; Tornero P; Herrero T
Allergol Immunopathol (Madr); 2001; 29(4):133-6. PubMed ID: 11674927
[TBL] [Abstract][Full Text] [Related]
20. Interaction of oxicam NSAIDs with DMPC vesicles: differential partitioning of drugs.
Chakraborty H; Roy S; Sarkar M
Chem Phys Lipids; 2005 Dec; 138(1-2):20-8. PubMed ID: 16183046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
